Top Markets
#1 Black Phoenix Black Phoenix +355.20%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.60%
#4 Akedo Akedo +60.88%
#5 OpenEden OpenEden +54.74%
#6 Acurast Acurast +29.22%
#7 BasedHype BasedHype +27.20%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +18.96%
#10 Ether.fi Ether.fi +17.29%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Classifica tra le azioni #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Prezzo delle azioni
$0.13607016
Ultima sincronizzazione: 2024-09-10
Capitalizzazione di mercato
$112.29K
Variazione (1 giorno)
22.46%
Variazione (1 anno)
0.00%
Paese
GB
Scambia BiVictriX Therapeutics Plc (BVX)

Categoria

Healthcare
Storico del prezzo dell'azione per BiVictriX Therapeutics Plc (BVX)
Prezzo di chiusura più alto: $0.11 il 2024-09-01

Prezzo di chiusura più basso: $0.30 il 2021-08-01
Storico del prezzo dell'azione di BiVictriX Therapeutics Plc dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE